Autologous transplantation of bone marrow-derived mononuclear and CD133+ cells in patients with decompensated cirrhosis

Archives of Iranian Medicine

Volumn 14, Issue 1, 2011, Pages 12-17

  Nikeghbalian, Saman ^a   Pournasr, Behshad ^b   Aghdami, Nasser ^b   Rasekhi, Alireza ^c   Geramizadeh, Bita ^d   Hosseini Asl, Seyed Mohammad Kazem ^e   Ramzi, Mani ^f   Kakaei, Farzad ^g   Namiri, Mehrnaz ^b   Malekzadeh, Reza ^h   Dizaj, Ahmad Vosough ^b   Malek Hosseini, Seyed Ali ^a   Baharvand, Hossein ^b,i  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Autologous transplantation; Bone marrow; Decompensated cirrhosis; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; LIVER ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; CD133+ CELL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KIDNEY FUNCTION TEST; KIDNEY PERFUSION; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER WEIGHT; MALE; MONONUCLEAR CELL; OUTCOME ASSESSMENT; PATIENT SAFETY; PORTAL VEIN THROMBOSIS; THERAPY EFFECT;

ADULT; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER REGENERATION; MALE; MONOCYTES; PEPTIDES; PORTAL VEIN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 78751545557     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Miro JM, Laguno M, Moreno A, Rimola A. Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol. 2006; 44: S140-S145.
2. Mohamadnejad M, Swenson ES. Induced pluripotent cells mimicking human embryonic stem cells. Arch Iran Med. 2008; 11: 125-128.
3. Khurana S, Mukhopadhyay A. In vitro transdifferentiation of adult hematopoietic stem cells: an alternative source of engraftable hepatocytes. J Hepatol. 2008; 49: 998-1007.
4. Yan Y, Xu W, Qian H, Si Y, Zhu W, Cao H, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int. 2009; 29: 356-365.
5. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol. 2009; 24: 70-77.
6. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008; 134: 2111-2121, 2121 e1-3.
7. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004; 40: 1304-1311.
8. Mirzania M, Ghavamzadeh A, Yaghmaie M, Sedighi N, Kamalian N, Alimoghaddam K, et al. Hepatocytes of donor origin in recipient liver after hematopoietic SCT in beta-thalassemia major patients. Bone Marrow Transplant. 2009. [Epub ahead of print].
9. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008; 135: 438-450.
10. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007; 13: 3359-3363.
11. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008; 103: 1952-1958.
12. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif. 2008; 41 (suppl 1): 115-125.
13. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006; 24: 1822-1830.
14. Furst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology. 2007; 243: 171-179.
15. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009; 21: 1199-1205.
16. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007; 10: 459-466.
17. Yannaki E, Anagnostopoulos A, Kapetanos D, Xagorari A, Iordanidis F, Batsis I, et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol. 2006; 34: 1583-1587.
18. am Esch JS, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005; 23: 463-470.
19. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006; 24: 2292-2298.
20. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007; 13: 1067-1073.
21. de Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells. 1998; 16: 387-396.
22. Haider H, Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol. 2005; 288: H2557-H2567.